Cardlytics, Inc. (NASDAQ:CDLX) Q2 2023 Earnings Call Transcript

UnidentifiedAnalyst: Great. I believe you kind of guided to around like $40 million, $42 million in cash OpEx before. Is that run rate — quarterly run rate is still safe to assume here? Or is there any changes to that number?

Karim Temsamani: Yes. I’ll let Rob take that on and add something, but that’s essentially roughly the current trend in our expenses line. I don’t know, Rob, if you want to add anything?

Robert Robinson: No. You certainly answered the question. It is no change from what we’ve told you guys in the past few quarters.

Operator: At this time, I am showing no further questions. I would now like to turn the conference back over to Karim for closing remarks. Please proceed.

Karim Temsamani: Thank you. Obviously, this brings the call to a close. I want to leave you all with this. Product is at the forefront of our strategy and it is helping us build stronger partnerships and new capabilities that will attract more advertisers to our business. And as you know, we are highly focused on the long-term financial health of the business. Our expectation is positive annual adjusted EBITDA and operating cash flow for 2024. We’ll continue to be disciplined as we make investments to reach our full potential. Thank you for your continued support, and I look forward to speaking with you all soon.

Operator: Thank you. This concludes today’s conference call. Thank you for participating. You may now disconnect.